Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
Detecting β in Animal Tissues Using Transcriptional Markers 2 Agonist approach
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
An animal tissue, β2 receptor technology, applied in biochemical equipment and methods, microbial determination/inspection, etc., can solve problems such as threats to the personal safety of consumers, and achieve the effect of monitoring
Active Publication Date: 2021-09-21
INST OF QUALITY STANDARD & TESTING TECH FOR AGRO PROD OF CAAS
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] Although the current Chinese standards and related laws and regulations have explicitly prohibited the addition of β to animal feed and drinking water 2 Receptor agonists, but they are still repeatedly banned, and the current mainstream drug residue analysis methods such as instrument analysis, immunoassay, sensor and chip analysis are all based on the detection of known drugs, and new drugs, as a loophole in monitoring, continue to threaten consumers. Personal safety
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0080] Embodiment 1, β in goat muscle tissue sample 2 Detection methods for receptor agonists
[0081] The goat muscle tissue samples of the experimental group (treatment) and the control group (control) used in this example were all provided by the Feed Research Institute of the Chinese Academy of Agricultural Sciences. The goat muscle tissue samples of the experimental group were goat muscle tissue samples fed to goats with ractopamine (Dr.Ehrenstorfer GmbH (Augsburg, Germany), LR0714001C), and the goat muscle tissue samples of the control group were goats that were not fed with ractopamine and any other beta 2 Agonists of goat muscle tissue.
[0082] Use ultra-high phase liquid chromatography-quadrupole mass spectrometry to measure the content of ractopamine in the samples of the experimental group and the control group, the internal reference is ractopamine (Dr.Ehrenstorfer GmbH (Augsburg, Germany), LR0714022C), and the quantitative ion pair is m / z 302.17507, m / z 308.2...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses the use of transcription markers to detect β in animal tissues 2 Agonist approach. The method provided by the present invention comprises: using fluorescent quantitative PCR to respectively amplify ADRB2, PRKACB, ADCY3, ATP1A3, ATP2A3, PTH, MYLK, TNF-α, IL1B genes and internal reference genes in the isolated animal tissues and / or organs According to the difference between each gene and the Ct value in the internal reference gene system and the corresponding formula, y1 and y2 are obtained respectively; according to the following method, determine whether the animal tissue and / or organ contains or is candidate to contain β 2 Receptor agonist: if y1≥y2, the animal tissue to be tested does not contain or candidate does not contain β 2 Receptor agonist, such as y1<y2, the animal tissue to be tested contains or is candidate to contain β 2 receptor agonist. The present invention can effectively solve β 2 The monitoring problem of receptor agonists, effectively realize the detection of β 2 Agonist monitoring.
Description
technical field [0001] The invention relates to the use of transcription markers to detect β in animal tissues in the field of biotechnology 2 Agonist approach. Background technique [0002] Beta agonists include nonselective beta agonists such as isoproterenol and selective cardiac beta 1 Agonists such as dobutamine, selective beta 2 Receptor agonists such as albuterol, tert-butyl, and other drugs. beta 2 Receptor agonist which excites the β on the surface of airway smooth muscle and mast cell membrane 2 Receptors, relax airway smooth muscle, reduce mast cell and basophil degranulation and the release of their mediators, reduce microvascular permeability, increase the swing of airway epithelial cilia, etc. to relieve asthma symptoms. beta 2 Agonists include: cimaterol, penbuterol, tobuterol, sibuterol, bromobuterol, mapbuterol, terbutaline, chlorprenaline, ractopamine, gram Renbuterol, albuterol, bambuterol, ritodrine, clenpro, zilpaterol, mapenterol, etc. [0003] ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.